Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.

Kim S. Bell-Anderson,L Aouad,Helen Williams,F R Sanz,Jenny L. Phuyal,Claire Z. Larter,Geoffrey C. Farrell,Ian D. Caterson

Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.

2011

Kim S. Bell-Anderson
L Aouad
Helen Williams
F R Sanz
Jenny L. Phuyal
Claire Z. Larter
Geoffrey C. Farrell
Ian D. Caterson

Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice

Keywords:

Antagonism
Insulin
Inflammation
Endocrinology
Internal medicine
Diabetes mellitus
Fatty liver
Rimonabant
Medicine
Cannabinoid
Receptor
Steatosis
saturated fat
Insulin resistance
Adipose tissue
White adipose tissue
Steatohepatitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations